"HVTN"
"HVTN"
About
About HVTN
Leadership
Senior Staff
Scientific Achievements
Scientific Programs
Scientific Programs Overview
HVTN Trials
Integrated Science Infographic
Scholar Awards
How To Apply
RAMP Scholar Profiles
Scientific Publications
Ancillary Studies Policy
Participate
Participate Overview
Study Clinics
The Right HIV Test
Information for Providers
Participants' Rights
Community
Community Overview
Good Participatory Practice
Community Advisory Board
HVTN Faith Initiative
Community Compass
Past Publications
HIV Study Basics
HIV Study Basics Overview
Key HIV Vaccine Topics
Types of Vaccines
How Vaccines Work
How HVTN Study Protocols are Developed
Using Antibodies for HIV Prevention
Ethics of HVTN Trials
HIV Vaccine Myths and Facts
HIV Awareness
HIV Resources & Links
News
HVTN News
News Releases
For The Media
Events
Careers
Contact Us
About
About HVTN
Leadership
Senior Staff
Scientific Achievements
Scientific Programs
Scientific Programs Overview
HVTN Trials
Integrated Science Infographic
Scholar Awards
How To Apply
RAMP Scholar Profiles
Scientific Publications
Ancillary Studies Policy
Participate
Participate Overview
Study Clinics
The Right HIV Test
Information for Providers
Participants' Rights
Community
Community Overview
Good Participatory Practice
Community Advisory Board
HVTN Faith Initiative
Community Compass
Past Publications
HIV Study Basics
HIV Study Basics Overview
Key HIV Vaccine Topics
Types of Vaccines
How Vaccines Work
How HVTN Study Protocols are Developed
Using Antibodies for HIV Prevention
Ethics of HVTN Trials
HIV Vaccine Myths and Facts
HIV Awareness
HIV Resources & Links
News
HVTN News
News Releases
For The Media
Events
Careers
Contact Us
News
HVTN News
Search and Filter
Apply
Clear all
Stories tagged study participation
Results per Page:
20
5
10
20
50
100
HVTN Launches First of Its Kind Volunteer Registry
Red Ribbon Registry Opens to Volunteers for HIV Vaccine Studies
HVTN News - May 18, 2022
Tags
HIV Vaccine Trials Network (HVTN)
clinical trials
study participation
Share
Study participants feel good when helping others, HVTN analysis shows
News Releases - December 01, 2021
Tags
study participation
clinical trials
hiv prevention trial
Share
HVTN study demonstrates anti-HIV antibody responses within 6 weeks of initial HIV vaccination
News Releases - October 01, 2019
Tags
antibody responses
hiv vaccine
study participation
Share
Mind the gap: The burden of HIV among racial and ethnic minority groups and their participation in preventive HIV vaccine clinical trials
News Releases - February 11, 2019
Tags
minority
racial disparities
clinical trials
study participation
diversity, equity and inclusion
Share
HVTN investigates ability of mobile technology to enhance data accuracy and completeness
News Releases - October 08, 2018
Tags
health technology
data analysis
study participation
hiv
Share
HVTN COVERAGE FROM ITS HOME INSTITUTION — FRED HUTCH
News on HVTN
Read MORE >
Test of a new 'germline-targeting' HIV vaccine prepares to launch
Vaccine’s unique protein designed to start process of building powerful antibodies against AIDS virus
May 19, 2022
Highlights of Fred Hutch science in 2021
From COVID-19 to cancer, Hutch scientists pursued new ideas to save lives
December 20, 2021
World AIDS Day 2021: Let's give the gifts of hope and focus to HIV research
HIV scientific infrastructure paved the way for the world’s COVID-19 response. Now, it’s time to return the favor.
December 1, 2021
AIDS@40: Stories of hope and heroes
The people and the science devoted to stopping HIV
May 27, 2021
Home
News
HVTN News
Last Modified, February 25, 2022
